The results of the CCK-8 cell proliferation assay showed that, following the knockdown of exon 2 in CDK4 using siRNA, the proliferation capacity of CRC cells was significantly reduced compared to the siNC group (Fig. 7b). The gene discussed is CDK4; the disease is colorectal carcinoma.